AMNEAL PHARMACEUTICALS, INC. Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-03.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2023-03-03
- AMNEAL PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2022 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- AMNEAL PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2020 was $1.38M, a 261.15% increase from fiscal 2019.
- AMNEAL PHARMACEUTICALS, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2019 was $381.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-03 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-03 |
| 2020-12-31 | $1.38M 10-K · filed 2023-03-03 |
| 2019-12-31 | $381.00K 10-K · filed 2022-03-01 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |